Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewAccelerating molecular discovery using an in silico design platform
Schrödinger will host a scientific workshop in Barcelona on July 8 to showcase how its molecular design platform leverages physics-based simulation and machine learning to accelerate drug discovery.
-
NewBioga and five Galician biotech companies to attend Swiss Biotech Day 2025 to network and ...
Bioga and five Galician biotech companies joined Swiss Biotech Day 2025, one of Europe’s leading life sciences events, to foster connections and explore partnerships with Swiss firms—highlighting
-
NewBCN HEALTH will present two communications at the Jornadas AES in June in Madrid
BCN HEALTH will participate in the Jornadas de la Asociación de Economía de la Salud (AES), which will take place in Madrid from June 18 to 20, with the presentation of two communications focused on
-
-
CompanyCIMAB
-
NewThe essential role of biotechnology in the production of safe, nutritious, and sustainable...
AseBio partners are leading the shift towards a more sustainable agri-food system, combining biotechnology, artificial intelligence, and regenerative practices to ensure safe and affordable food for
-
Press releaseThe essential role of biotechnology in the production of safe, nutritious, and sustainable...
Over 800 million people suffer from chronic hunger, and biotechnology is revolutionizing the way we produce food, offering more sustainable and efficient alternatives. In the face of hunger challenges
-
NewNatac strengthens its Branded Ingredients catalogue with the launch of Oligut
New patented product combines olive tree polyphenols and triterpenes to provide chronic inflammation control and improve gut function.
-
NewSodena leads BioSintNA, the Synthetic Biology Business Plan in Navarra
Navarre takes a strategic step toward the future with the launch of BioSintNA, an ambitious synthetic biology business plan promoted by Sodena and the Government of Navarre. The initiative aims to
-
NewProtoQSAR strengthens its environmental commitment at SETAC Europe 2025
ProtoQSAR continues to expand its role in the global scientific community through its active participation in SETAC Europe 2025, held in Vienna from May 11 to 15. As one of the leading events in
-
NewMIMO Biosciences receives the EmprendeXXI Award in Navarra
Biotech company MIMO Biosciences, a spin-off from the CIMA University of Navarra, has been honored with the prestigious 2025 EmprendeXXI Award. The prize is promoted by CaixaBank through DayOne and
-
CompanyMELIUS ORGANICS
-
NewGENESIS Biomed holds its 2025 Annual Symposium at the Parc Científic de Barcelona
The event featured the intervention of Josep Lluís Falcó, CEO of the company, who addressed the trends and challenges of the sector; Andreu M. Climent, CEO of CORIFY, as a success story of a start-up
-
NewAn Innovative App developed at San Cecilio Clinical Hospital with Support from ibs.GRANADA...
Manos Seguras 3.0, designed in collaboration with a Granada-based startup and supported by ibs.GRANADA, boosts the prevention of healthcare-associated infections
-
NewaptaTargets transferred ApTOLL to Merck
ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck to assume clinical development and commercialization of ApTOLL.
-
-
NewKadans becomes a new member of the Spanish Association of Science and Technology Parks
Kadans Science Partner, a European leader in innovation campus development, has joined the Association of Science and Technology Parks of Spain (APTE) as an affiliate member. With operations across
-
NewALLOX, the startup exploring allosterism to revolutionize drug development
Recently established at the Barcelona Science Park, ALLOX is harnessing cutting-edge technology that merges genetics, artificial intelligence, and energy modeling to explore allosterism — a crucial
-
NewCase study: Development of the new GMP plant of 53Biologics
53Biologics strengthens its biopharmaceutical capacity in Spain with a new GMP facility in Valladolid, designed in collaboration with Klinea to meet the highest standards and optimize the production
-
NewRepronovo raises $65 million Series A financing to advance phase 2 clinical trials of nove...
Round led by Jeito Capital, co-led by AXA IM Alts and M Ventures, with strong syndicate support from Ysios Capital and ALSA Ventures
-
NewGate2Brain secures over €700,000 in CDTI Multipaís funding to advance a novel therapy ag...
Gate2Brain secures key funding to advance its groundbreaking pediatric brain tumor therapy